Layne Johnson
Medical · Sterlington, LANPI 1982631156
Payments from drug & device makers
Across 99 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$399
- Novo Nordisk$253
- Otsuka America Pharmaceutical, Inc.$179
- AbbVie$154
- Lilly USA, LLC$141
- Boehringer Ingelheim$128
- plus $594 from 14 others
What the payments were for
- Food & beverage$1,849100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 21 | $399 |
| Novo Nordisk | 15 | $253 |
| Otsuka America Pharmaceutical, Inc. | 7 | $179 |
| AbbVie | 7 | $154 |
| Lilly USA, LLC | 9 | $141 |
| Boehringer Ingelheim | 7 | $128 |
| AstraZeneca | 5 | $122 |
| Avanir Pharmaceuticals, Inc. | 6 | $102 |
| Astellas Pharma US Inc | 4 | $72 |
| Neurocrine Biosciences, Inc. | 3 | $63 |
| Pfizer | 4 | $57 |
| Exact Sciences | 2 | $35 |
| Abbott | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Smith+Nephew | 1 | $15 |
| Amgen | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$1,849 in reported general payments places this provider in the 65th percentile of 253 medical providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 38 | $32,388 |
| OzempicSemaglutide | 14 | $13,340 |
| EliquisApixaban | 18 | $10,155 |
| Spiriva RespimatTiotropium Bromide | 11 | $6,864 |
| LinzessLinaclotide | 11 | $5,847 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $1,587 |
| Atorvastatin Calcium | 96 | $868 |
| Gabapentin | 50 | $600 |
| Levothyroxine Sodium | 37 | $317 |
| Duloxetine Hcl | 12 | $314 |
| Metoprolol Succinate | 19 | $274 |
| Potassium Chloride | 20 | $258 |
| CefuroximeCefuroxime Axetil | 17 | $254 |
| Losartan Potassium | 32 | $238 |
| Celecoxib | 16 | $223 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat | $128 | $39,25249 claims |
| Novo NordiskOzempic | $253 | $13,34014 claims |
| PfizerEliquis | $57 | $10,15518 claims |
| AbbVieLinzess | $154 | $5,84711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 253 medical providers in Louisiana.
Other medical in Sterlington
- Kristi RobertBaton Rouge$486K
- John Paul ThevenotMonroe$56K
- Vickie RiceBaton Rouge$19K
- Mary McFerrenShreveport$16K
- Rachel RhinehartJefferson$16K
- Sydney FussellCovington$16K
- Thomas BriscoeLafayette$13K
- Seth HendrixShreveport$12K
- Jessica PelusoNatchitoches$12K
- Heather RoanBossier City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.